Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025

Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) has scheduled its second quarter 2025 financial results release for August 4, 2025 after market close. The company will host a conference call at 5:00 p.m. Eastern Time to discuss financial performance and business updates.

Investors can access the earnings call through two methods: a webcast via the company's Investor Relations website for those planning to listen only, or a separate registration link for those intending to ask questions. The company recommends registering at least 10 minutes before the call. A replay will be available on the Investor Relations website approximately two hours after the event and will be archived for two weeks.

News Market Reaction

-1.22%

1 alert

-1.22% News Effect

On the day this news was published, INSP declined 1.22%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

MINNEAPOLIS, July 07, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2025 after the close of trading on Monday, August 4. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q2 2025 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Inspire's Q2 2025 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call. 

Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443

FAQ

When will Inspire Medical Systems (INSP) report Q2 2025 earnings?

Inspire Medical Systems will report Q2 2025 earnings on Monday, August 4, 2025 after the market closes.

What time is Inspire Medical Systems' Q2 2025 earnings call?

The earnings conference call will begin at 5:00 p.m. Eastern Time on August 4, 2025.

How can I access Inspire Medical Systems' Q2 2025 earnings call?

You can access the call through either the webcast link on Inspire's Investor Relations website for listening only, or register separately if you plan to ask questions during the call.

How long will Inspire Medical's Q2 2025 earnings call replay be available?

The earnings call replay will be available on the company's Investor Relations website for two weeks following the call.